News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

APT Pharmaceutical LLC Closes New $22 Million Funding Round


10/4/2007 8:29:36 AM

BURLINGAME, CA--(Marketwire - October 04, 2007) - APT Pharmaceuticals, a specialty drug development company focused on effective treatments for significant unmet medical needs, announced today that it has closed a $22 million Series A-2 round of financing. New investors Versant Ventures and Great Point Partners joined existing firms Vivo Ventures and Charter Life Sciences in the round. Coinciding with the funding, Camille Samuels, Managing Director, Versant Ventures and David Kroin, Managing Director, Great Point Partners have joined the APT board.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES